NSE filing, NSE: MARUSHIKA. Summary written from the filing by ALFA Finder's alert engine.
Marushika Technology Ltd: key numbers
- Share price
- ₹116.00
- Market cap
- ₹99.03 Cr
- Revenue (annual)
- ₹116.4 Cr
- Net profit (annual)
- ₹8.95 Cr
- P/E (TTM)
- 11.1×Sector 23.0×
- Promoter holding
- 58.19%
- FII holding
- 5.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Marushika Technology Ltd
All →Marushika Technology Annual General Meeting
Marushika Technology Limited held its 16th Annual General Meeting on September 25, 2026. The meeting covered the adoption of financial statements and various board appointments.
Marushika Technology Partnership
Marushika Technology commenced a partnership with Sanare Medical as exclusive distributor of ExoAtlet II. The agreement targets government procurement via GeM across Indian public institutions.
Marushika Technology Other Announcement
Marushika Technology Limited has shifted its registered office to a new location in New Delhi, effective September 14, 2026.
Marushika Technology Other Announcement
Marushika Technology dispatched physical letters to shareholders providing the weblink to access the Annual Report and Notice of the 16th Annual General Meeting. This complies with regulatory requirements.
Marushika Technology Annual General Meeting
Marushika Technology Limited will hold its 16th Annual General Meeting on September 25, 2026. The agenda includes financial statement adoption and director appointments.
Marushika Technology Bags ₹2.41 Cr Order
Marushika Technology Limited received an order worth ₹2.41 Crore from the National Highways Authority of India for street lighting system works over 5 years.
- Value
- ₹2.41 Cr
- Execution
- 5 years
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.